Vicarious Surgical Inc (OTCPK:RBOT)

Q3 2025 Vicarious Surgical Inc Earnings Call Transcript

Nov 12, 2025 / 09:30 PM GMT

Release Date Price: $4.12 (-9.85%)

Transcript 10-Q8-K

Key Points

Positve

Vicarious Surgical Inc (RBOT) has significantly reduced its operating expenses by 35% compared to the previous year, demonstrating effective cost management.
The company successfully raised approximately $5.9 million through a registered direct offering, strengthening its balance sheet.
Vicarious Surgical Inc (RBOT) is actively working towards a design freeze of its production equivalent system by the end of 2026, which is crucial for commercialization.
The company is engaging with a well-known consulting firm to optimize outsourcing opportunities, aiming to improve capital efficiency while maintaining engineering progress.
Vicarious Surgical Inc (RBOT) is enhancing transparency and communication with stakeholders by providing regular updates on its platform development through LinkedIn and its investor relations website.

Negative

The company is facing potential disruptions due to its outsourcing initiatives, which could impact the timeline for achieving design freeze.
Vicarious Surgical Inc (RBOT) reported a GAAP net loss of $11.1 million for the third quarter of 2025, indicating ongoing financial challenges.
The cash burn rate remains high, with approximately $10.5 million burned in the third quarter, and the company expects a full-year cash burn of around $50 million.
A recent layoff of about 15% of employees highlights the company's efforts to control costs but also indicates potential operational challenges.
The timeline for system build completion and regulatory testing is still uncertain, with potential delays due to the outsourcing process.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RBOT.N - Vicarious Surgical Inc
Q3 2025 Vicarious Surgical Inc Earnings Call
Nov 12, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon.

Thank you for attending the Vicarious Surgicals 20,253 quarter earnings call. My name is Cameron and I'll be your moderator for today. All lines will be muted during the presentation.

All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. If you would like to ask a question, please press star followed by one on your telephone keypad, and I would now like to pass the conference over to your host, Marissa Beich with the Gil Martin Group. You may proceed.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.